Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02. (Q39485433)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02. |
scientific article |
Statements
1 reference
Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02. (English)
1 reference
Thierry Facon
1 reference
Philippe Moreau
1 reference
Murielle Roussel
1 reference
Jean Paul Fermand
1 reference
Bertrand Arnulf
1 reference
Margaret Macro
1 reference
Lotfi Benboubker
1 reference
Anne Marie Stoppa
1 reference
Laurent Garderet
1 reference
Gerald Marit
1 reference
Olivier Decaux
1 reference
Nathalie Meuleman
1 reference
Michel Attal
1 reference
Claire Mathiot
1 reference
Beatrice Thielemans
1 reference
Marie Odile Petillon
1 reference
Catherine Traulle
1 reference
Bernadette Hennache
1 reference
Mauricette Michallet
1 reference
Intergroupe Francophone du Myélome
1 reference
Brigitte Kolb
1 reference
Sabine Bréchignac
1 reference
Bruno Royer
1 reference
Denis Caillot
1 reference
14 January 2013
1 reference
1 reference
121
1 reference
11
1 reference
1968-1975
1 reference
Identifiers
1 reference
1 reference